LOOK AT THIS IF YOU'RE INTERESTED IN:
Examining the cost implications of providing immunization services through a range of strategies in a safe manner during COVID-19.
HOW YOU CAN USE THIS MATERIAL:
Country stakeholders should use these findings to facilitate discussions at the country-level to inform country planning and resource mobilization efforts.
This study, conducted by researchers from ThinkWell and the Harvard T.H. Chan School of Public Health, illustrates the potential cost implications of providing immunization services through a range of strategies in a safe manner which can serve as a benchmark for program managers and policy makers on the additional budget required. These findings can also help country practitioners and global development partners planning the continuation of immunization services in the context of COVID-19.
- Implementing a range of measures to protect health workers and communities from COVID-19 transmission could result in a per-facility start-up cost of $466–799 for routine fixed-site delivery, $12–220 for routine outreach delivery, and $12–108 per immunization campaign site.
- A recurrent monthly cost of $137–1,024 for fixed-site delivery and $152–848 for outreach delivery per facility could be incurred, and a $0.32–0.85 increase in the cost per dose during campaigns.